Oseltamivir Phosphate Powder, For Suspension
Product Images NDC 50090-4188

2 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 50090-4188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (F7fa7c11 5ffe 45c4 95a3 Faf9c94e28fb 01)

Image 1 (F7fa7c11 5ffe 45c4 95a3 Faf9c94e28fb 01)
Chemical structure of Oseltamivir Phosphate, showing the molecule with labeled carbon positions and functional groups including an ethyl ester, amino group, and phosphate conjugate.*
FDA Label Image

Label Image (Lbl500904188)

Label Image (Lbl500904188)
Label for Oseltamivir Phosphate powder for suspension, 6 mg/mL, by A-S Medication Solutions, LLC. The label includes storage instructions to keep the dry powder at 77 degrees Fahrenheit, and indicates a 60 mL usable volume after constitution. The package includes 60 mL of oral suspension powder with details such as lot number and NDC 50090-4188-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.